Cita APA

Cruickshanks, N., Hamed, H. A., Booth, L., Tavallai, S., Syed, J., Sajithlal, G. B., . . . Dent, P. (2013). Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy. Landes Bioscience.

Citación estilo Chicago

Cruickshanks, Nichola, Hossein A. Hamed, Laurence Booth, Seyedmehrad Tavallai, Jahangir Syed, Gangadharan B. Sajithlal, Steven Grant, Andrew Poklepovic, y Paul Dent. Histone Deacetylase Inhibitors Restore Toxic BH3 Domain Protein Expression in Anoikis-resistant Mammary and Brain Cancer Stem Cells, Thereby Enhancing the Response to Anti-ERBB1/ERBB2 Therapy. Landes Bioscience, 2013.

Cita MLA

Cruickshanks, Nichola, et al. Histone Deacetylase Inhibitors Restore Toxic BH3 Domain Protein Expression in Anoikis-resistant Mammary and Brain Cancer Stem Cells, Thereby Enhancing the Response to Anti-ERBB1/ERBB2 Therapy. Landes Bioscience, 2013.